Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
clinical trials
6
×
fda
life sciences
national blog main
boston blog main
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national top stories
new york top stories
san francisco blog main
san francisco top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
drugs
eli lilly
genentech
investing
national
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
4d molecular therapeutics
abbvie
acne
agenus
aimmune therapeutics
akouos
What
approved
6
×
drug
6
×
fda
medicines
therapeutics
approval
developed
friday
late
new
oral
therapy
treat
won
affects
agency
aimmune
allergy
americans
announced
atrophy
awarded
bio
cholesterol
class
combo
companies
daily
date
decision
developing
digital
disease
eli
epidemic
esperion
esperion’s
evrysdi
fatty
frenzied
Language
unset
Current search:
drug
×
biotech
×
approved
×
" clinical trials "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines